全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

高血压基底节出血的治疗进展
Advances in the Treatment of Hypertensive Basal Ganglia Hemorrhage

DOI: 10.12677/acm.2025.1541157, PP. 2087-2093

Keywords: 高血压基底节出血,保守治疗,手术
Hypertensive Ganglionic-Basal Hemorrhage
, Conservative Treatment, Surgery

Full-Text   Cite this paper   Add to My Lib

Abstract:

高血压基底节出血(HGBH)是高血压脑出血最常见的类型,具有高致残率和高死亡率。HGBH病理机制与长期高血压导致的豆纹动脉损伤(如脂质透明变性、微动脉瘤形成)及血压骤升引发的血管破裂有关,血肿的压迫、炎症反应和继发性脑损伤进一步加重神经功能缺损。HGBH分为保守治疗与手术治疗,根据患者的病情评估综合选择。保守治疗的重点是精准血压管理(如早期降压至130~140 mmHg)、颅内压控制(甘露醇、高渗盐水及亚低温治疗)、神经保护(依达拉奉、铁螯合剂)及并发症防治(深静脉血栓预防)。外科治疗以手术为主,包括小骨窗显微开颅术、神经内镜手术及机器人辅助立体定向穿刺术,治疗目的主要是以最小的创伤,高效清除血肿。目前,HBGH的未来治疗发展方向包括跨学科协作、新型药物研发及智能化精准诊疗体系的建立,以此改善患者神经功能预后及生活质量。
Hypertensive ganglionic-basal hemorrhage (HGBH) is the most common type of hypertensive intracerebral hemorrhage, characterized by high rates of disability and mortality. The pathological mechanisms of HGBH are associated with long-term hypertension-induced lenticulostriate artery damage (e.g., lipohyalinosis and microaneurysm formation) and acute blood pressure surges leading to vascular rupture. Subsequent neurological deficits are exacerbated by hematoma compression, inflammatory responses, and secondary brain injury. Treatment strategies for HGBH are categorized into conservative and surgical approaches, selected based on comprehensive patient assessment. Conservative management focuses on precise blood pressure control (e.g., early reduction to 130~140 mmHg), intracranial pressure regulation (mannitol, hypertonic saline, and mild hypothermia therapy), neuroprotection (edaravone, iron chelators), and complication prevention (deep vein thrombosis prophylaxis). Surgical interventions, including small bone window microcraniotomy, neuroendoscopic surgery, and robot-assisted stereotactic puncture surgery, aim to evacuate hematomas efficiently with minimal trauma. Future directions for HGBH treatment emphasize interdisciplinary collaboration, novel drug development, and intelligent precision diagnosis and treatment systems to improve neurological outcomes and quality of life.

References

[1]  Magid-Bernstein, J., Girard, R., Polster, S., Srinath, A., Romanos, S., Awad, I.A., et al. (2022) Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circulation Research, 130, 1204-1229.
https://doi.org/10.1161/circresaha.121.319949
[2]  Ren, J., Wu, X., Huang, J., Cao, X., Yuan, Q., Zhang, D., et al. (2020) Intracranial Pressure Monitoring-Aided Management Associated with Favorable Outcomes in Patients with Hypertension-Related Spontaneous Intracerebral Hemorrhage. Translational Stroke Research, 11, 1253-1263.
https://doi.org/10.1007/s12975-020-00798-w
[3]  Hostettler, I.C., Seiffge, D.J. and Werring, D.J. (2019) Intracerebral Hemorrhage: An Update on Diagnosis and Treatment. Expert Review of Neurotherapeutics, 19, 679-694.
https://doi.org/10.1080/14737175.2019.1623671
[4]  游潮, 刘鸣, 李浩. 高血压脑出血诊治中的若干问题[J]. 中国脑血管病杂志, 2011, 8(4): 169-171.
[5]  Manning, L., Hirakawa, Y., Arima, H., Wang, X., Chalmers, J., Wang, J., et al. (2014) Blood Pressure Variability and Outcome after Acute Intracerebral Haemorrhage: A Post-Hoc Analysis of INTERACT2, a Randomised Controlled Trial. The Lancet Neurology, 13, 364-373.
https://doi.org/10.1016/s1474-4422(14)70018-3
[6]  Arima, H., Heeley, E., Delcourt, C., Hirakawa, Y., Wang, X., Woodward, M., et al. (2015) Optimal Achieved Blood Pressure in Acute Intracerebral Hemorrhage. Neurology, 84, 464-471.
https://doi.org/10.1212/wnl.0000000000001205
[7]  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Investigators (2010) Antihypertensive Treatment of Acute Cerebral Hemorrhage. Critical Care Medicine, 38, 637-648.
https://doi.org/10.1097/ccm.0b013e3181b9e1a5
[8]  Greenberg, S.M., Ziai, W.C., Cordonnier, C., Dowlatshahi, D., Francis, B., Goldstein, J.N., et al. (2022) 2022 Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage: A Guideline from the American Heart Association/American Stroke Association. Stroke, 53, e282-e361.
https://doi.org/10.1161/str.0000000000000407
[9]  Sandset, E.C., Anderson, C.S., Bath, P.M., Christensen, H., Fischer, U., Gąsecki, D., et al. (2021) European Stroke Organisation (ESO) Guidelines on Blood Pressure Management in Acute Ischaemic Stroke and Intracerebral Haemorrhage. European Stroke Journal, 6, II-II.
[10]  Selway, L.D. (2010) State of the Science: Hypoxic Ischemic Encephalopathy and Hypothermic Intervention for Neonates. Advances in Neonatal Care, 10, 60-66.
https://doi.org/10.1097/anc.0b013e3181d54b30
[11]  Gluckman, P., Wyatt, J., Azzopardi, D., Ballard, R., Edwards, A., Ferriero, D., et al. (2005) Selective Head Cooling with Mild Systemic Hypothermia after Neonatal Encephalopathy: Multicentre Randomised Trial. The Lancet, 365, 663-670.
[12]  张晓佳, 周毅, 卢军见, 等. 亚低温对新生大鼠缺氧缺血性脑损伤后NF-κB基因的表达变化[J]. 中西医结合心脑血管病杂志, 2014, 12(8): 999-1001.
[13]  王鹤, 郑兆聪, 陈宏颉. 高血压脑出血早期血肿扩大的预测指标及防治手段[J]. 中华神经医学杂志, 2014, 13(10): 1074-1077.
[14]  嵇朋, 裴娜, 王继立, 等. 应用头部亚低温治疗高血压脑出血临床效果分析[J]. 中国实用神经疾病杂志, 2018, 21(8): 838-841.
[15]  石代乐, 高继英, 杨李鹏, 等. 依达拉奉配合醒脑静注射液治疗脑出血临床疗效及对神经细胞因子和炎性反应递质的影响[J]. 实用医院临床杂志, 2022, 19(4): 36-40.
[16]  王运良, 曾志磊, 娄季宇. 脑出血神经保护的治疗进展[J]. 中国实用神经疾病杂志, 2011, 14(23): 90-93.
[17]  宋平, 雷盼, 华秋伟, 等. 神经干细胞在脑出血治疗中的应用研究进展[J]. 中国医药, 2023, 18(5): 769-772.
[18]  刘兵兵. DNA/RNA杂化纳米复合物通过捕获毒性蛋白及调控小胶质细胞表型治疗脑出血研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2023.
[19]  Kim, C.H., Lee, S.W., Kim, Y.H., Sung, S.K., Son, D.W. and Song, G.S. (2019) Predictors of Hematoma Enlargement in Patients with Spontaneous Intracerebral Hemorrhage Treated with Rapid Administration of Antifibrinolytic Agents and Strict Conservative Management. Korean Journal of Neurotrauma, 15, 126-134.
https://doi.org/10.13004/kjnt.2019.15.e23
[20]  Mayer, S.A., Davis, S.M., Skolnick, B.E., Brun, N.C., Begtrup, K., Broderick, J.P., et al. (2009) Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII? Stroke, 40, 833-840.
https://doi.org/10.1161/strokeaha.108.524470
[21]  Goldstein, J.N., Fazen, L.E., Wendell, L., et al. (2008) Risk of Thromboembolism Following Acute Intracerebral Hemor-rhage. Neurocritical Care, 23, 28-34
[22]  Sandercock, P. and Dennis, M. (2001) Venous Thromboembolism after Acute Stroke. Stroke, 32, 1443-1448.
https://doi.org/10.1161/01.str.32.6.1443-b
[23]  中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019) [J]. 中华神经科杂志, 2019, 52(12): 994-1005.
[24]  董宁, 胡福英, 袁华兵. 抗凝药物在脑出血并发静脉血栓栓塞症防治中的应用研究进展[J]. 山东医药, 2024, 64(29): 99-102.
[25]  Maira, G., Anile, C., Colosimo, C. and Rossi, G.F. (2002) Surgical Treatment of Primary Supratentorial Intracerebral Hemorrhage in Stuporous and Comatose Patients. Neurological Research, 24, 54-60.
https://doi.org/10.1179/016164102101199549
[26]  Fernandes, H.M., Gregson, B., Siddique, S. and Mendelow, A.D. (2000) Surgery in Intracerebral Hemorrhage: The Uncertainty Continues. Stroke, 31, 2511-2516.
https://doi.org/10.1161/01.str.31.10.2511
[27]  Powers, W.J., Zazulia, A.R., Videen, T.O., Adams, R.E., Yundt, K.D., Aiyagari, V., et al. (2001) Autoregulation of Cerebral Blood Flow Surrounding Acute (6 to 22 Hours) Intracerebral Hemorrhage. Neurology, 57, 18-24.
https://doi.org/10.1212/wnl.57.1.18
[28]  宫睿. 高血压脑出血的外科治疗进展[J]. 中外医疗, 2013, 32(32): 196, 198.
[29]  Auer, L.M., Deinsberger, W., Niederkorn, K., Gell, G., Kleinert, R., Schneider, G., et al. (1989) Endoscopic Surgery versus Medical Treatment for Spontaneous Intracerebral Hematoma: A Randomized Study. Journal of Neurosurgery, 70, 530-535.
https://doi.org/10.3171/jns.1989.70.4.0530
[30]  (2017) Correction to: ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for Brain Hemorrhage: A Multicenter Randomized Controlled Trial. Stroke, 48, e335.
[31]  陈福, 张书奎, 李炳臻, 等. 神经内镜治疗基底节区高血压脑出血的进展[J]. 中华实验外科杂志, 2022, 39(8): 1630-1632.
[32]  程刚, 张世渊, 贾禄, 等. 神经导航联合神经内镜小骨窗下治疗高血压脑出血的疗效分析[J]. 中华神经外科疾病研究杂志, 2024, 18(4): 27-30.
[33]  晋新军, 张晓阳. 高血压脑出血3D-slicer软件辅助神经内镜血肿清除术与显微镜辅助骨瓣开颅血肿清除术近期效果比较研究[J]. 河南外科学杂志, 2024, 30(1): 48-51.
[34]  丁俊, 张毅明, 余浩, 等. 机器人辅助下立体定向穿刺与开颅血肿清除治疗高血压脑出血的疗效比较[J]. 兰州大学学报(医学版), 2024, 50(4): 36-40.
[35]  王焕明, 胡飞, 陈俊, 等. 神经外科机器人在高血压脑出血手术的临床应用(附54例分析) [J]. 中国微侵袭神经外科杂志, 2024, 28(2): 90-93.
[36]  Zou, D., Chen, X., Chen, S., Zhang, P. and Lu, Y. (2024) Impact of Endoscopic Surgery versus Robot CAS-R-2 Assisted with Stereotactic Drainage on Prognosis of Basal Ganglia Hypertensive Intracerebral Hemorrhage. World Neurosurgery, 181, e589-e596.
https://doi.org/10.1016/j.wneu.2023.10.097
[37]  Xiong, R., Li, F. and Chen, X. (2020) Robot-Assisted Neurosurgery versus Conventional Treatment for Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Journal of Clinical Neuroscience, 82, 252-259.
https://doi.org/10.1016/j.jocn.2020.10.045
[38]  Wu, Z., Chen, D., Pan, C., Zhang, G., Chen, S., Shi, J., et al. (2023) Surgical Robotics for Intracerebral Hemorrhage Treatment: State of the Art and Future Directions. Annals of Biomedical Engineering, 51, 1933-1941.
https://doi.org/10.1007/s10439-023-03295-x
[39]  Hemphill, J.C., Greenberg, S.M., Anderson, C.S., Becker, K., Bendok, B.R., Cushman, M., et al. (2015) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association Stroke, 46, 2032-2060.
https://doi.org/10.1161/str.0000000000000069

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133